Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02620813 · ClinicalTrials.gov registry record · Early Phase 1
De Novo Lipogenesis of Sebaceous Glands in Acne
A Early Phase 1 study, sponsored by University of California, Davis.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 32
- Enrollment target
NCT02620813 is a Early Phase 1 study that has completed, run by University of California, Davis. The registered enrollment target is 32 participants.
The verdict
NCT02620813, a Early Phase 1 study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
There are two purposes of this study: 1. First, the investigators want to see what the differences are in de novo sebaceous lipid production of people with and without acne. 2. Secondly, the investigators want to know what happens to sebaceous gland de novo lipid production before and after treatment with topical tretinoin and oral isotretinoin.
Interventions
- DRUG Tretinoin
- DRUG Isotretinoin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-10-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02620813
The ClinicalTrials.gov registry entry for NCT02620813 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tretinoin is the first listed.
NCT02620813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02620813 about?
NCT02620813 is a clinical study titled "De Novo Lipogenesis of Sebaceous Glands in Acne". There are two purposes of this study: 1. First, the investigators want to see what the differences are in de novo sebaceous lipid production of people with and without acne. 2. Secondly, the investigators want to know what happens to sebaceous gland de novo lipid production before and after treatme...
What is the current status of trial NCT02620813?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 32 participants. The study started on 2015-10. Estimated completion is 2017-10-12.
What interventions are being tested in trial NCT02620813?
The interventions under investigation include: Tretinoin (DRUG), Isotretinoin (DRUG).
Who is sponsoring clinical trial NCT02620813?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.